Nanoparticle-Based Targeted Therapies in Cancer: Opportunities and Challenges

Abstract

Nanoparticle-based targeted therapies have emerged as a promising strategy for the treatment of cancer, offering significant advantages over traditional therapeutic approaches. These therapies leverage the unique properties of nanoparticles, such as their size, surface characteristics, and ability to be functionalized with specific ligands, to deliver drugs directly to tumor cells, minimizing systemic toxicity and enhancing therapeutic efficacy. This paper explores the opportunities provided by nanoparticlebased therapies, including their ability to overcome biological barriers, improve drug solubility, and enable precise targeting of cancer cells. Additionally, we discuss the challenges involved in the development of nanoparticle-based cancer treatments, including issues related to biocompatibility, potential immune responses, and manufacturing scalability. The future of this technology is promising, with ongoing research aimed at overcoming these hurdles and optimizing the clinical translation of nanoparticle-based therapies in oncology